GE HealthCare Technologies Inc.
GEHCHealthcareNASDAQMedical Devices · Last scanned Oct 26, 2026
Scan Results
Daily timeframeGE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States,. With a market capitalization of $32.50B, it sits in large-cap territory. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).
Market Cap
$32.50B
Beta
0.85
P/E (TTM)
16.43
P/E (Fwd)
13.20
EPS (TTM)
$4.35
EPS (Fwd)
$5.41
ROE
19.4%
ROA
5.1%
Cash
$2.08B
Total Debt
$10.54B
Free CF
$1.57B
52W Change
-8.8%
Annual Financials
Cash vs Debt
Where GEHC stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, GEHC finished 4.15% above its 150-day moving average ($66.98) and 0.87% below its 200-day moving average ($70.37). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is GEHC overbought or oversold?
At the October 20, 2026 close, GEHC's RSI(14) was 62.2, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $2.08B in cash, though total debt stands at $10.54B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $1.57B in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 19.4% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 5.1% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $18.34B to $20.62B.
GE HealthCare Technologies Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence GE HealthCare Technologies Inc.'s trajectory.